Trevor, Stewart, Burton & Jacobsen’s GSK GSK Stock Holding History

Trevor, Stewart, Burton & Jacobsen’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$3.39M	Buy	67,249 +10,928	+19%	+$557K	3.84%	10
2015 Q3	$2.71M	Sell	56,321 -13,904	-20%	-$724K	3.14%	18
2015 Q2	$3.66M	Buy	70,225 +508	+0.7%	+$28.6K	3.26%	18
2015 Q1	$4.02M	Sell	69,717 -57,319	-45%	-$3.29M	3.34%	18
2014 Q4	$6.37M	Buy	127,036 +71,024	+127%	+$3.97M	5.08%	3
2014 Q3	$3.22M	Buy	56,012 +4,492	+9%	+$275K	2.06%	24
2014 Q2	$3.44M	Buy	+51,520	New	+$3.49M	1.79%	25

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Trevor, Stewart, Burton & Jacobsen's GSK Position: Q4 2015 in Review

Trevor, Stewart, Burton & Jacobsen increased its GSK (GSK) stake by 19% in Q4 2015, buying an estimated $557K and bringing the position to 67,249 shares worth $3.39M. The position accounts for 3.84% of the portfolio, ranked #10.

Trevor, Stewart, Burton & Jacobsen first reported a position in GSK in Q2 2014 and has held it in 7 quarters since. The position peaked at $6.37M in Q4 2014. 719 funds tracked by Wall St. Rank hold GSK as of Q4 2015.

Trevor, Stewart, Burton & Jacobsen held 67,249 shares of GSK worth $3.39M as of Q4 2015.
Trevor, Stewart, Burton & Jacobsen bought 10,928 GSK shares in Q4 2015, an estimated $557K.
GSK made up 3.84% of Trevor, Stewart, Burton & Jacobsen's portfolio in Q4 2015, its #10 holding.
Trevor, Stewart, Burton & Jacobsen first reported a position in GSK in Q2 2014 and has held it in 7 quarters since.
Trevor, Stewart, Burton & Jacobsen's GSK position peaked at $6.37M in Q4 2014.
719 funds tracked by Wall St. Rank held GSK as of Q4 2015.

Based on Trevor, Stewart, Burton & Jacobsen's 13F filing for Q4 2015, filed 12 Feb 2016.